Compare CVKD & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVKD | MOBX |
|---|---|---|
| Founded | 2022 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 22.0M |
| IPO Year | 2023 | N/A |
| Metric | CVKD | MOBX |
|---|---|---|
| Price | $7.94 | $0.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 61.9K | ★ 18.0M |
| Earning Date | 11-10-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,912,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.87 |
| 52 Week Low | $6.42 | $0.17 |
| 52 Week High | $22.90 | $1.67 |
| Indicator | CVKD | MOBX |
|---|---|---|
| Relative Strength Index (RSI) | 45.99 | 36.84 |
| Support Level | $6.55 | $0.21 |
| Resistance Level | $8.79 | $0.28 |
| Average True Range (ATR) | 0.57 | 0.05 |
| MACD | 0.23 | 0.00 |
| Stochastic Oscillator | 65.65 | 28.61 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.